Medindia LOGIN REGISTER
Medindia
Advertisement

Cynosure Introduces Affirm CO2(TM) Workstation for Advanced Ablative Therapy

Thursday, July 17, 2008 General News
Advertisement
WESTFORD, Mass., July 17 Cynosure, Inc.(Nasdaq: CYNO), a leading developer and manufacturer of a broad array oflight-based aesthetic treatment systems, today launched the Affirm CO2(TM), anablative workstation with a proprietary scanning delivery system that combinesablative CO2 skin resurfacing and rejuvenation in a single laser system.
Advertisement

"Affirm CO2 is a dynamic platform to address deep wrinkles, significantphotoaging, severe scar damage and other difficult-to-treat skin conditions,"said Cynosure President and Chief Executive Officer Michael Davin. "Our newestflagship workstation integrates a carbon dioxide laser, with Micro Ablativescanning technology and is considered the most effective treatment option fordeep wrinkles. The result is a system that helps patients look years youngerwith minimal downtime, and affords physicians substantial flexibility intreatment options. The Affirm CO2 system offers a range of settings thatenable physicians to customize the treatment based on the aesthetic goals anddowntime expectations of individual patients."
Advertisement

The Affirm CO2 system with Micro Ablative scanning technology is thenewest flagship addition to Cynosure's Affirm(TM) family of products foranti-aging indications. The original Affirm Workstation, introduced in 2006,delivers a non-ablative treatment designed to produce progressive results inpatients with fine to moderate wrinkles and sun-damaged skin. By contrast,the Affirm CO2 workstation uses an ablative approach to target the epidermaland dermal layer with the objective of treating dyschromia, deep wrinkles andsignificant photoaging.

According to the Millennium Research Group, the skin rejuvenation marketis expected to grow annually by 18 percent, resulting in a $239 millionindustry by 2010, with approximately 4.4 million procedures performed per yearby 2010.

"The Affirm CO2 targets a large and growing market of consumers for whomage is not an impediment to vitality or a youthful appearance," Davin said."In a country where 12,000 people turn 50 every day, and the population overthe age of 55 is expected to grow 60% over the next 20 years, we believe themarket opportunity for Cynosure is significant."

"With power up to 30 watts and an adjustable pulse duration between 0.2and 2 milli seconds, Affirm CO2 offers the versatility of performing a lightto aggressive treatment with a single laser," said Bruce Katz, M.D., ClinicalProfessor of Dermatology at The Mount Sinai School of Medicine, Director ofthe Cosmetic Surgery & Laser Clinic at Mount Sinai Medical Center and Directorof the Juva Skin & Laser Center in New York. "Another important benefit isthe range of scanning options, which enable users not only to shortentreatment time, but to provide uniform coverage across the entire treatmentarea."

Initial U.S. shipments of Affirm CO2 are expected to begin in the thirdquarter of 2008.

About Cynosure, Inc.

Cynosure, Inc. develops and markets aesthetic treatment systems that areused by physicians and other practitioners to perform non-invasive andminimally invasive procedures to remove hair, treat vascular lesions,rejuvenate skin through the treatment of shallow vascular and pigmentedlesions, laser lipolysis and temporarily reduce the appearance of cellulite.Cynosure's products include a broad range of laser and other light-basedenergy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, aswell as intense pulsed light. Cynosure was founded in 1991.

For corporate or product information, contact Cynosure at 800-886-2966, orvisit http://www.cynosure.com.

Forward-Looking Statements

Any statements in this press release about future expectations, plans andprospects for Cynosure, Inc., including statements about the company'sexpectations regarding the performance and market acceptance of the Affirm CO2and future financial pe
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close